KIVU-305

KIVU-305 · Kivu Bioscience Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KIVU-305, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]